This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Anthem (ANTM) Q4 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Anthem's (ANTM) fourth-quarter results benefit from higher revenues stemming from robust Medicaid and Medicare businesses, partly offset by higher costs.
Boston Scientific (BSX) LOTUS Edge Recall to Mar Q4 Earnings
by Zacks Equity Research
Per Boston Scientific's (BSX) October update, it has started to see strong region-wise recovery.
Find 'Strong Buy' Stocks Near New Highs with this Screener
by Benjamin Rains
Why not look at stocks that have climbed along with the broader market and are trading near new highs...
Thermo Fisher (TMO) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Thermo Fisher's (TMO) Life-Science Solutions and Specialty Diagnostics segments are expected to have contributed, banking on COVID-19-led growing healthcare needs.
Anthem (ANTM) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Anthem (ANTM) is likely to have witnessed increased revenues and a rise in membership during Q4, offset by an escalating expense level.
HCA Healthcare (HCA) Steps Up Efforts to Boost PPE Output
by Zacks Equity Research
HCA Healthcare (HCA) invests in new business to meet the buoyancy in demand for PPE and surgical masks.
Community Health (CYH) Unit Announces Junior Note Offerings
by Zacks Equity Research
Community Health's (CYH) wholly-owned arm exhibits monetary discretion by issuing notes to procure funds.
UnitedHealth (UNH) Q4 Earnings Top Estimates, Revenues up Y/Y
by Zacks Equity Research
UnitedHealth's (UNH) fourth-quarter results benefit from higher revenues and return of healthcare utilization to normalcy level, partly offset by higher costs.
Demand for COVID-19 Tests to Drive Abbott (ABT) Q4 Earnings
by Zacks Equity Research
Within EPD, Abbott (ABT) is expected to have witnessed visible signs of rebound through Q4.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include: ABM Industries, ManpowerGroup, Builders FirstSource, Signet Jewelers and Tenet Healthcare
by Zacks Equity Research
Zacks.com featured highlights include: ABM Industries, ManpowerGroup, Builders FirstSource, Signet Jewelers and Tenet Healthcare
5 Broker-Friendly Stocks in View Amid COVID-Led Economic Gloom
by Maharathi Basu
Brokers' evaluation should come in handy for investors. Evidently, broker-friendly stocks like ABM, Manpower (MAN), Builders FirstSource (BLDR), Signet Jewelers (SIG) and Tenet Healthcare (THC) are in focus.
Zacks.com featured highlights include: Tenet Healthcare, Avery Dennison, ArcBest, Mosaic and Installed Building Products
by Zacks Equity Research
Zacks.com featured highlights include: Tenet Healthcare, Avery Dennison, ArcBest, Mosaic and Installed Building Products
Here's Why You Should Bet on Acadia Healthcare (ACHC) Stock
by Zacks Equity Research
Acadia Healthcare (ACHC) has been benefiting from growing demand for behavioral health services, high revenues and solid cash flows.
Here's Why You Should Steer Clear of Ensign Group (ENSG) Now
by Zacks Equity Research
Escalating expense level and weak patient volumes make Ensign Group (ENSG) an unattractive bet.
Upgraded Broker Ratings Make These 5 Stocks Worth a Look Now
by Swayta Shah
After in-depth research, brokers rate a company's stock. Hence, we select Tenet Healthcare (THC), Avery Dennison (AVY), ArcBest (ARCB), Mosaic Company (MOS) & Installed Building Products (IBP) as these witness ratings upgrade.
Encompass Health (EHC) Forms JV to Boost Presence in Illinois
by Zacks Equity Research
Encompass Health (EHC) forms JV with UnityPoint Health - Trinity for constructing an inpatient rehabilitation hospital in Illinois to provide better health services in the state.
Why Should You Retain HCA Healthcare (HCA) in Your Portfolio?
by Zacks Equity Research
Riding high on its growth efforts and cost-curbing initiatives, HCA Healthcare (HCA) holds potential to reap benefits for investors.
Ensign Group (ENSG) on Buyout Spree, Expands in California
by Zacks Equity Research
Ensign Group (ENSG) acquires three skilled nursing facilities in Southern California, which further reinforces its efforts to strengthen nationwide presence.
Enforcement of Price Transparency Rules Puts Hospitals in a Fix
by Zacks Equity Research
Hospital companies might feel the heat from price transparency rules, effective Jan 1, 2021.
Here's Why Community Health (CYH) Stock is an Attractive Bet Now
by Zacks Equity Research
Community Health (CYH) remains well-poised for growth on the back of constant efforts to streamline operations and reduced operating costs.
Molina Healthcare (MOH) Up 52.5% in a Year: More Room to Run?
by Zacks Equity Research
Molina Healthcare's (MOH) strategic initiatives augur well for its revenues, which in turn, might appreciate its stock price.
Select Medical (SEM) Rides on a Diversified Business Profile
by Zacks Equity Research
Select Medical's (SEM) supremacy in a fragmented market and its affordable healthcare services in each of its business segments bode well for the long haul.
Tenet Healthcare (THC) Up 126.9% in 6 Months: More Room for Rally?
by Zacks Equity Research
Tenet Healthcare's (THC) strategic measures and cost-controlling efforts are expected to drive its margins, which in turn, might inflate its share price.
Tenet Healthcare (THC) to Rejig Business by Selling Urgent Care
by Zacks Equity Research
Tenet Healthcare (THC) to restructure its ambulatory care business by axing the urgent care business and focusing on growing the ambulatory surgery business.